Proteomics International Laboratories Limited (PIQ.AX)
- Previous Close
1.0900 - Open
1.1000 - Bid 1.0900 x 1039400
- Ask 1.1050 x 480500
- Day's Range
1.0650 - 1.1400 - 52 Week Range
0.7000 - 1.4000 - Volume
36,513 - Avg. Volume
302,043 - Market Cap (intraday)
142.673M - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date Jul 21, 2024 - Jul 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.38
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
www.proteomics.com.auRecent News: PIQ.AX
Performance Overview: PIQ.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PIQ.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PIQ.AX
Valuation Measures
Market Cap
142.67M
Enterprise Value
137.75M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
224.70
Price/Book (mrq)
26.66
Enterprise Value/Revenue
236.98
Enterprise Value/EBITDA
-17.01
Financial Highlights
Profitability and Income Statement
Profit Margin
-194.61%
Return on Assets (ttm)
-49.23%
Return on Equity (ttm)
-97.26%
Revenue (ttm)
3.03M
Net Income Avi to Common (ttm)
-5.9M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
4.97M
Total Debt/Equity (mrq)
0.89%
Levered Free Cash Flow (ttm)
-3.32M
Research Analysis: PIQ.AX
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: PIQ.AX
PIQ.AX does not have Company Insights